These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8845449)

  • 1. Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis.
    Friedlander AM; Welkos SL; Worsham PL; Andrews GP; Heath DG; Anderson GW; Pitt ML; Estep J; Davis K
    Clin Infect Dis; 1995 Oct; 21 Suppl 2():S178-81. PubMed ID: 8845449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.
    Grosfeld H; Cohen S; Bino T; Flashner Y; Ber R; Mamroud E; Kronman C; Shafferman A; Velan B
    Infect Immun; 2003 Jan; 71(1):374-83. PubMed ID: 12496187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Protection against Pneumonic and Bubonic Plague after a Single Oral Vaccination.
    Derbise A; Hanada Y; Khalifé M; Carniel E; Demeure CE
    PLoS Negl Trop Dis; 2015; 9(10):e0004162. PubMed ID: 26473734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of in vitro correlate assays of immunity to infection with Yersinia pestis.
    Bashaw J; Norris S; Weeks S; Trevino S; Adamovicz JJ; Welkos S
    Clin Vaccine Immunol; 2007 May; 14(5):605-16. PubMed ID: 17376861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yersinia pestis IS1541 transposition provides for escape from plague immunity.
    Cornelius CA; Quenee LE; Elli D; Ciletti NA; Schneewind O
    Infect Immun; 2009 May; 77(5):1807-16. PubMed ID: 19237527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis.
    Anderson GW; Worsham PL; Bolt CR; Andrews GP; Welkos SL; Friedlander AM; Burans JP
    Am J Trop Med Hyg; 1997 Apr; 56(4):471-3. PubMed ID: 9158060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 8. Yersinia pestis YadC: a novel vaccine candidate against plague.
    Murphy BS; Wulff CR; Garvy BA; Straley SC
    Adv Exp Med Biol; 2007; 603():400-14. PubMed ID: 17966436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.
    Titball RW; Howells AM; Oyston PC; Williamson ED
    Infect Immun; 1997 May; 65(5):1926-30. PubMed ID: 9125581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague.
    Lemaître N; Sebbane F; Long D; Hinnebusch BJ
    Infect Immun; 2006 Sep; 74(9):5126-31. PubMed ID: 16926404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.
    Galván EM; Nair MK; Chen H; Del Piero F; Schifferli DM
    Infect Immun; 2010 Aug; 78(8):3443-53. PubMed ID: 20498260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of New Virulence Factors and Vaccine Candidates for
    Andersson JA; Sha J; Erova TE; Fitts EC; Ponnusamy D; Kozlova EV; Kirtley ML; Chopra AK
    Front Cell Infect Microbiol; 2017; 7():448. PubMed ID: 29090192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN; Sriranganathan N; Lees CJ; Mizel SB
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.
    Sha J; Endsley JJ; Kirtley ML; Foltz SM; Huante MB; Erova TE; Kozlova EV; Popov VL; Yeager LA; Zudina IV; Motin VL; Peterson JW; DeBord KL; Chopra AK
    J Clin Microbiol; 2011 May; 49(5):1708-15. PubMed ID: 21367990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of
    Dudte SC; Hinnebusch BJ; Shannon JG
    Front Cell Infect Microbiol; 2017; 7():358. PubMed ID: 28848716
    [No Abstract]   [Full Text] [Related]  

  • 18. Mice naturally resistant to Yersinia pestis Delta pgm strains commonly used in pathogenicity studies.
    Congleton YH; Wulff CR; Kerschen EJ; Straley SC
    Infect Immun; 2006 Nov; 74(11):6501-4. PubMed ID: 16954401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular Immunization of Mice with a Live-Attenuated Triple Mutant of Yersinia pestis CO92 Induces Robust Humoral and Cell-Mediated Immunity To Completely Protect Animals against Pneumonic Plague.
    Tiner BL; Sha J; Ponnusamy D; Baze WB; Fitts EC; Popov VL; van Lier CJ; Erova TE; Chopra AK
    Clin Vaccine Immunol; 2015 Dec; 22(12):1255-68. PubMed ID: 26446423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A live attenuated strain of Yersinia pestis KIM as a vaccine against plague.
    Sun W; Six D; Kuang X; Roland KL; Raetz CR; Curtiss R
    Vaccine; 2011 Apr; 29(16):2986-98. PubMed ID: 21320544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.